BMJ Open Diabetes Research & Care
is an open access diabetes journal from the ADA and BMJ that strives to publish innovative studies on diabetes in all disciplines and therapeutic areas as quickly and transparently as possible.
Impact Factor: 4.1
Citescore: 3.5
All metrics >>
Latest Articles
Epidemiology/Health services research:
Interplay between chronic widespread pain and lifestyle factors on the risk of type 2 diabetes: longitudinal data from the Norwegian HUNT Study22 September 2023
Clinical care/Education/Nutrition:
Real-life data of hypoglycemic events in children and adolescents with type 1 diabetes22 September 2023
Genetics/Genomes/Proteomics/Metabolomics:
Circulating metabolites improve the prediction of renal impairment in patients with type 2 diabetes21 September 2023
Epidemiology/Health services research:
Detailed descriptions of physical activity patterns among individuals with diabetes and prediabetes: the Lolland-Falster Health Study12 September 2023
Cardiovascular and metabolic risk:
Uncovering heterogeneous cardiometabolic risk profiles in US adults: the role of social and behavioral determinants of health12 September 2023
Most Read Articles
Cardiovascular and metabolic risk:
Use of oral diabetes medications and the risk of incident dementia in US veterans aged ≥60 years with type 2 diabetes11 October 2022
Cardiovascular and metabolic risk:
How sweet is your love? Disentangling the role of marital status and quality on average glycemic levels among adults 50 years and older in the English Longitudinal Study of Ageing6 February 2023
Emerging technologies, pharmacology and therapeutics:
Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized, open-label, …15 November 2022
Epidemiology/Health services research:
Prevalence of diabetes and pre-diabetes in Sri Lanka: a new global hotspot–estimates from the Sri Lanka Health and Ageing Survey 2018/201915 February 2023
Cardiovascular and Metabolic Risk
Cardiovascular and metabolic risk:
Uncovering heterogeneous cardiometabolic risk profiles in US adults: the role of social and behavioral determinants of health12 September 2023
Cardiovascular and metabolic risk:
MDRD is the eGFR equation most strongly associated with 4-year mortality among patients with diabetes in Colombia20 July 2023
Cardiovascular and metabolic risk:
Efficacy and safety of luseogliflozin in Caucasian patients with type 2 diabetes: results from a phase III, randomized, placebo-controlled, clinical trial16 June 2023
Cardiovascular and metabolic risk:
Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering13 June 2023
Altmetrics
